Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals. She appears on CNBC's Business Day programming, contributes to CNBC.com and is based at the network's global headquarters in Englewood Cliffs, N.J.
Tirrell has covered development of new drugs for Alzheimer's, cancer and rare diseases, and tracked public health emergencies from Ebola to Zika. Her work has explored why fewer drugs are developed for children, chronicled the sequencing of her own genome, and followed the manufacturing of a flu shot from egg to pharmacy. In 2014, she revealed the agonizing decision-making behind Compassionate Use of unapproved drugs, and in 2016, she reported extensively on drug pricing controversies and the impact of politics on development of new medicines.
Prior to joining CNBC, Tirrell covered the biotechnology industry for Bloomberg News, where she also contributed to Bloomberg Television and Bloomberg Businessweek.
She holds a master's degree in journalism from Northwestern University and a bachelor's degree in English and music from Wellesley College.
Follow her on Twitter @megtirrell.
This Saturday's March for Science is trying hard to be a nonpartisan event, but some may not see it that way.
An analysis commissioned by pharmacy benefits managers revealed no correlation between drug prices and rebates.
Discussing who is to blame for higher drug pricing with Mark Merritt, PCMA CEO; Stephen Ubl, Pharmaceutical Research and Manufacturers of America (PhRMA) president and ceo; and CNBC's Meg Tirrell.
CNBC's Meg Tirrell breaks down Abbott Labs' quarterly results which posted EPS of $0.48 adj. on revenues of $6.335 billion.
CNBC's Meg Tirrell takes a look at what the FDA's rejection of the drug means for Eli Lilly and partner Incyte.
CNBC's Meg Tirrell reports the latest in biotech news as Neurocine Biosciences receives FDA approval for their movement disorder drug, as well as Smithfield Foods setting up a bioscience unit with a potential for pig-to-human organ transplants.